173 related articles for article (PubMed ID: 23233876)
1. Non-destructive inhibition of metallofullerenol Gd@C(82)(OH)(22) on WW domain: implication on signal transduction pathway.
Kang SG; Huynh T; Zhou R
Sci Rep; 2012; 2():957. PubMed ID: 23233876
[TBL] [Abstract][Full Text] [Related]
2. Dual inhibitory pathways of metallofullerenol Gd@C₈₂(OH)₂₂ on matrix metalloproteinase-2: molecular insight into drug-like nanomedicine.
Kang SG; Araya-Secchi R; Wang D; Wang B; Huynh T; Zhou R
Sci Rep; 2014 Apr; 4():4775. PubMed ID: 24758941
[TBL] [Abstract][Full Text] [Related]
3. Metallofullerenol Gd@C₈₂(OH)₂₂ distracts the proline-rich-motif from putative binding on the SH3 domain.
Kang SG; Huynh T; Zhou R
Nanoscale; 2013 Apr; 5(7):2703-12. PubMed ID: 23423582
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine.
Kang SG; Zhou G; Yang P; Liu Y; Sun B; Huynh T; Meng H; Zhao L; Xing G; Chen C; Zhao Y; Zhou R
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15431-6. PubMed ID: 22949663
[TBL] [Abstract][Full Text] [Related]
5. Potential toxicity mechanism of MoS
Meng Y; Liu R; Zhu M; Zhai H; Ren C
Colloids Surf B Biointerfaces; 2020 Dec; 196():111317. PubMed ID: 32818927
[TBL] [Abstract][Full Text] [Related]
6. The Molecular Mechanism of Human Voltage-Dependent Anion Channel 1 Blockade by the Metallofullerenol Gd@C
Wang X; Yang N; Su J; Wu C; Liu S; Chang L; Plant LD; Meng X
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053271
[TBL] [Abstract][Full Text] [Related]
7. Gd-Metallofullerenol Nanomaterial Suppresses Pancreatic Cancer Metastasis by Inhibiting the Interaction of Histone Deacetylase 1 and Metastasis-Associated Protein 1.
Pan Y; Wang L; Kang SG; Lu Y; Yang Z; Huynh T; Chen C; Zhou R; Guo M; Zhao Y
ACS Nano; 2015 Jul; 9(7):6826-36. PubMed ID: 26083726
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of Gd@C
Liu J; Kang SG; Wang P; Wang Y; Lv X; Liu Y; Wang F; Gu Z; Yang Z; Weber JK; Tao N; Qin Z; Miao Q; Chen C; Zhou R; Zhao Y
Biomaterials; 2018 Jan; 152():24-36. PubMed ID: 29080421
[TBL] [Abstract][Full Text] [Related]
9. A Novel Drug Design Strategy: An Inspiration from Encaging Tumor by Metallofullerenol Gd@C
Li J; Chen L; Yan L; Gu Z; Chen Z; Zhang A; Zhao F
Molecules; 2019 Jun; 24(13):. PubMed ID: 31252662
[TBL] [Abstract][Full Text] [Related]
10. Gd-Metallofullerenol nanoparticles cause intracellular accumulation of PDGFR-α and morphology alteration of fibroblasts.
Tang J; Guo M; Wang P; Liu J; Xiao Y; Cheng W; Gao J; Hu W; Miao QR
Nanoscale; 2019 Mar; 11(11):4743-4750. PubMed ID: 30604821
[TBL] [Abstract][Full Text] [Related]
11. Fullerenes and their derivatives as inhibitors of tumor necrosis factor-α with highly promoted affinities.
Wu G; Gao XJ; Jang J; Gao X
J Mol Model; 2016 Jul; 22(7):161. PubMed ID: 27316702
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger.
Yin JJ; Lao F; Meng J; Fu PP; Zhao Y; Xing G; Gao X; Sun B; Wang PC; Chen C; Liang XJ
Mol Pharmacol; 2008 Oct; 74(4):1132-40. PubMed ID: 18635669
[TBL] [Abstract][Full Text] [Related]
13. Charging nanoparticles: increased binding of Gd@C
Chen SH; Kang SG; Luo J; Zhou R
Nanoscale; 2018 Mar; 10(12):5667-5677. PubMed ID: 29528358
[TBL] [Abstract][Full Text] [Related]
14. The pharmaceutical multi-activity of metallofullerenol invigorates cancer therapy.
Li J; Chen L; Su H; Yan L; Gu Z; Chen Z; Zhang A; Zhao F; Zhao Y
Nanoscale; 2019 Aug; 11(31):14528-14539. PubMed ID: 31364651
[TBL] [Abstract][Full Text] [Related]
15. FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands.
Bedford MT; Chan DC; Leder P
EMBO J; 1997 May; 16(9):2376-83. PubMed ID: 9171351
[TBL] [Abstract][Full Text] [Related]
16. Metallofullerene nanoparticles promote osteogenic differentiation of bone marrow stromal cells through BMP signaling pathway.
Yang K; Cao W; Hao X; Xue X; Zhao J; Liu J; Zhao Y; Meng J; Sun B; Zhang J; Liang XJ
Nanoscale; 2013 Feb; 5(3):1205-12. PubMed ID: 23299786
[TBL] [Abstract][Full Text] [Related]
17. Identification differential behavior of Gd@C
Liu X; Ying X; Li Y; Yang H; Hao W; Yu M
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Oct; 203():383-396. PubMed ID: 29894950
[TBL] [Abstract][Full Text] [Related]
18. Solution structures of the YAP65 WW domain and the variant L30 K in complex with the peptides GTPPPPYTVG, N-(n-octyl)-GPPPY and PLPPY and the application of peptide libraries reveal a minimal binding epitope.
Pires JR; Taha-Nejad F; Toepert F; Ast T; Hoffmüller U; Schneider-Mergener J; Kühne R; Macias MJ; Oschkinat H
J Mol Biol; 2001 Dec; 314(5):1147-56. PubMed ID: 11743730
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis through ER stress and TP53 in MCF-7 cells by the nanoparticle [Gd@C82(OH)22]n: A systems biology study.
Wang L; Meng J; Cao W; Li Q; Qiu Y; Sun B; Li LM
Methods; 2014 Jun; 67(3):394-406. PubMed ID: 24440483
[TBL] [Abstract][Full Text] [Related]
20. Antioxidative function and biodistribution of [Gd@C82(OH)22]n nanoparticles in tumor-bearing mice.
Wang J; Chen C; Li B; Yu H; Zhao Y; Sun J; Li Y; Xing G; Yuan H; Tang J; Chen Z; Meng H; Gao Y; Ye C; Chai Z; Zhu C; Ma B; Fang X; Wan L
Biochem Pharmacol; 2006 Mar; 71(6):872-81. PubMed ID: 16436273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
